Serum Institute’s Covishield supplies begin moving from Pune unit for distribution across nation | Latest News India - Hindustan Times
close_game
close_game

Serum Institute’s Covishield supplies begin moving from Pune unit for distribution across nation

Jan 12, 2021 08:20 AM IST

The Government of India formally sent a purchase order to the company on Monday evening for 11 million doses of Covishield, at a special price of Rs200 per dose for the first million doses

Supplies of Covishield, Serum Institute of India’s Oxford-AstraZeneca vaccine against Coronavirus disease (Covid-19), have begun moving from the company’s manufacturing facility in Pune early today.

Police personnel guard the trucks to be used to transport the Covishield vaccine from Serum Institute of India to different parts of the country, in Pune on January 11. (PTI)
Police personnel guard the trucks to be used to transport the Covishield vaccine from Serum Institute of India to different parts of the country, in Pune on January 11. (PTI)

The supplies will further be distributed to close to 60 cold storage points spread across the country for the nationwide vaccination drive on January 16 .

Hindustan Times - your fastest source for breaking news! Read now.

The first step after a purchase is made is for the manufacturer to deliver supplies by air to the primary vaccine stores run by the Union health ministry, which are called Government Medical Stores Depot (GMSD).

There are four such large depots functional at the moment in the country , one each in Karnal, Mumbai, Chennai and Kolkata. A manufacturer will deliver to one of these depots or sometimes even multiple depots, depending on the agreement signed with the government.

From these main depots, the supplies will be diverted to two points in refrigerated or insulated vans. One of the deployment points is the state vaccine stores that are 56 in number spread across various states.

From there on, it is the responsibility either of the state governments or Union Territory administration to deploy the stock further as per the state requirement. From the state stores, the supplies will be sent in refrigerated and insulated vans to the district vaccine stores, which is also a temperature control facility,

The Government of India formally sent a purchase order to the company on Monday evening for 11 million doses of Covishield, at a special price of Rs200 per dose for the first million doses.

SII is the local manufacturers for Oxford-AstraZeneca vaccine, and has also conducted clinical trials of the vaccine in India. Currently, phase 3 trials are going on in the country.

Initially, the deal is for procuring 11 million doses that is expected to cover the first phase of the vaccination drive involving 10 million healthcare workers across the country. There is also the plan to procure about 45 million more doses by April, 2021.

The government is keeping a margin of about 10%, to factor in wastage possibility of the vaccine, especially at the vaccination sites.

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
  • ABOUT THE AUTHOR
    author-default-90x90

    Rhythma Kaul works as an assistant editor at Hindustan Times. She covers health and related topics, including ministry of health and family welfare, government of India.

SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, March 28, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On